Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Aug 2026 for Seres Therapeutics, Inc..
Filing timeline
BuySaleKelly Brady
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kelly Brady: trading record in brief
This profile gathers the share dealings of Kelly Brady in Seres Therapeutics, Inc. We count 2 filings; the first trade dates from 15 August 2026 and the latest from 17 August 2026.
No open-market purchase appears, only 1 sale worth €251. Besides market trades, the filings include 1 option exercise.
The latest filing, published on 18 August 2026, reports an option exercise in Seres Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kelly Brady
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
181 sharesCommon StockSEC:0001193125-26-355734:0
64 shares@ US$4.55Common StockSEC:0001193125-26-355734:1
2 of 2 declarations
